Description

Ipamorelin 10MG

We provide Ipamorelin as a 10MG synthetic pentapeptide research compound with a stated 99.1% purity. Furthermore, the compound acts as a selective growth hormone secretagogue through the ghrelin receptor (GHS-R), making it relevant to controlled research involving pituitary signaling, growth hormone release, and endocrine regulation.

Ipamorelin Key Attributes

• Brand: AvigenLab
• Product Name: Ipamorelin
• Quantity: 10MG
• Stated Purity: 99.1%
• Molecular Type: Synthetic Pentapeptide
• Sequence: Aib-His-D-2-Nal-D-Phe-Lys-NH₂
• Sequence Length: 5 Amino Acids
• Molecular Formula: C₃₈H₄₉N₉O₅
• Molecular Weight: 711.9 g/mol
• CAS Number: 170851-70-4
• Product Format: Vial
• Classification: Research Use Only
• Human Use: Not For Human Use

Ipamorelin Product Overview

We provide Ipamorelin for research involving growth hormone secretion, GHS-R1a signaling, pituitary somatotroph activity, and the GH–IGF-1 axis. Moreover, published research characterizes the peptide as Aib-His-D-2-Nal-D-Phe-Lys-NH₂ and demonstrates growth hormone-releasing activity in experimental systems.

Explore additional research materials through our Online Store.

Product Identification

We identify Ipamorelin through its 10MG quantity, stated 99.1% purity, peptide classification, and vial presentation. Accordingly, these characteristics provide straightforward reference points for laboratory inventory and product documentation.

Product Category

We classify Ipamorelin within our research peptide collection for endocrine and neuroendocrine investigations. Furthermore, researchers have studied its selective growth hormone secretagogue activity in vitro and in vivo, including its interaction with a GHRP-like receptor.

Scientific Characteristics

The molecular structure contains five amino-acid residues. In particular, PubChem identifies the sequence as Aib-His-D-2-Nal-D-Phe-Lys-NH₂, with a molecular formula of C₃₈H₄₉N₉O₅ and molecular weight of 711.9 g/mol. Consequently, its defined structure provides a clear molecular reference for laboratory research.

Research Applications

We position Ipamorelin for research involving GHS-R1a activity, growth hormone release, pituitary signaling, endocrine regulation, and related IGF-1-axis investigations. Additionally, published research found that it stimulates GH release through a GHRP-like receptor and demonstrated high GH-releasing potency in experimental models.

Furthermore, the original pharmacological characterization demonstrated growth hormone release from primary rat pituitary cells and identified a GHRP-like receptor mechanism. Therefore, the compound provides a defined research subject for investigating receptor-mediated endocrine signaling.

Product Configuration

We provide the material in a 10MG vial carrying a stated 99.1% purity designation. Consequently, the defined quantity, peptide identity, purity specification, and physical presentation establish clear inventory references.

Moreover, the individual-vial configuration distinguishes this presentation from combination products containing other growth-hormone-related peptides. Researchers can therefore document the material according to its specific molecular identity and product configuration.

Product Features

The primary features include a 10MG quantity, 99.1% stated purity, five-amino-acid structure, and research-use presentation. Moreover, our label communicates Not For Human Use | Research Use Only.

Additionally, the defined molecular sequence and established receptor research profile provide useful reference points for laboratory documentation. Consequently, researchers can distinguish this material from other secretagogue and peptide products within our collection.

Product Specifications

The molecular sequence, formula, molecular weight, and CAS number correspond with the chemical identity recorded by PubChem.

Intended Research Context

We identify the material as Research Use Only and Not For Human Use. Accordingly, researchers can examine the compound within controlled experimental systems without treating laboratory findings as established therapeutic outcomes.

Furthermore, the scientific literature establishes a clear relationship between this peptide class and growth hormone secretagogue receptor activity. Nevertheless, experimental findings can vary according to the biological model, experimental conditions, concentration, and measured endpoint.

Packaging Information

Our Ipamorelin 10MG presentation uses a clearly labeled AvigenLab vial. Furthermore, the packaging displays the 10MG quantity, stated 99.1% purity, and Research Use Only classification.

Additionally, the vial presentation provides straightforward product identification for inventory and catalog management. You can explore related research materials through our Catalog.

Regulatory Information

We classify the material as Research Use Only and maintain the Not For Human Use designation throughout our product documentation. Therefore, published studies do not constitute regulatory approval for this specific AvigenLab presentation.

Moreover, scientific research can establish molecular characteristics and experimental activity without establishing therapeutic efficacy. Accordingly, our documentation focuses on the compound’s identity, research relevance, specifications, and published scientific characteristics.

Storage and Handling

We recommend following the storage and handling conditions specified in the applicable AvigenLab product documentation. Furthermore, researchers should maintain appropriate laboratory handling practices and follow product-specific documentation.

Because peptide stability can depend on formulation, packaging, environmental exposure, and other product-specific variables, we avoid assigning unsupported storage parameters. Consequently, researchers can rely on the applicable product documentation rather than generalized assumptions.

Market Availability

Our 10MG presentation provides a defined research peptide configuration within our collection. Moreover, the quantity, stated purity, molecular identity, vial format, and Research Use Only designation create clear reference points for laboratory inventory.

Likewise, the compound has an established research history in growth hormone secretagogue biology. Its original characterization demonstrated potent GH-releasing activity in experimental systems and identified its activity through a GHRP-like receptor.

Product Reference

Our product provides a defined synthetic pentapeptide carrying a stated 99.1% purity designation. Consequently, researchers can reference the material according to its molecular sequence, quantity, purity, vial presentation, and research classification.

Furthermore, its established research profile connects the compound with GHS-R signaling, growth hormone secretion, pituitary somatotroph activity, and endocrine research. Therefore, the 10MG AvigenLab presentation provides a clearly documented research material for controlled laboratory investigation.

For additional product information, researchers can also visit our Shop.